<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02626598</url>
  </required_header>
  <id_info>
    <org_study_id>IIS2202</org_study_id>
    <nct_id>NCT02626598</nct_id>
  </id_info>
  <brief_title>A Study Evaluating Blended Belotero for the Treatment of Etched-in Fine Facial Lines</brief_title>
  <official_title>A Study Evaluating Blended Belotero for the Treatment of Etched-in Fine Facial Lines</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Skin Care and Laser Physicians of Beverly Hills</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merz Aesthetics Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Skin Care and Laser Physicians of Beverly Hills</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single center study for adult females or males ages 25 to 75 years who are seeking
      treatment for etched-in fine lines of the cutaneous lip, and/or radial cheek area, and/or
      nasolabial folds, and/or melolabial folds, and/or forehead. The purpose of this study is to
      evaluate blended Belotero for the treatment of etched-in fine facial lines and to monitor for
      adverse events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a study to evaluate the effects of Belotero blended with 0.1 cc of 1% lidocaine with
      epinephrine per 1.0 cc of Belotero in the treatment of etched-in fine facial lines. 30 adults
      scheduled to have blended Belotero injected into fine lines of the cutaneous lip, and/or
      radial cheek area, and/or nasolabial folds, and/or melolabial folds, and/or forehead will be
      evaluated. The blended Belotero will be injected intradermally into these etched-in fine
      lines. The patients will be given diary cards to document potential adverse events. 2 weeks
      after receiving injections of the blended Belotero the subjects will return to have
      photographs taken, have their treated fine lines evaluated, and complete a self assessment
      questionnaire. Touch-up injections are common clinical practice and if additional touch-ups
      would improve their result, those subjects can be re-treated at this visit. Those subjects
      who are touched up will return to the clinic for an additional follow up visit and
      photographs 2 weeks later. All subjects will return to the clinic 12 weeks and 24 weeks after
      their last injection for photographs and evaluations. Improvement assessments will be made by
      investigator ratings at each visit. Investigator ratings for the cutaneous lip and the
      forehead area are based on the Merz Aesthetic Validated Assessment Scales. Investigator
      ratings for the radial cheek area, nasolabial folds, and melolabial folds are based on the
      Validated Lemperle Facial Wrinkle Scales.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>26 Weeks</target_duration>
  <primary_outcome>
    <measure>Investigator Fine Facial Line Evaluations (Merz Aesthetic Validated Assessment Scales for cutaneous lip and the forehead and Validated Lemperle Facial Wrinkle Scales for the radial cheek, nasolabial folds, and melolabial folds)</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>Investigator evaluations and ratings of fine facial lines will be made at each visit. Investigator ratings for the cutaneous lip and the forehead area are based on the Merz Aesthetic Validated Assessment Scales. Investigator ratings for the radial cheek area, nasolabial folds, and melolabial folds are based on the Validated Lemperle Facial Wrinkle Scales.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Diary Cards Documenting Adverse Events</measure>
    <time_frame>2-4 weeks</time_frame>
    <description>Patients will be given diary cards to document any potential adverse events for 2 weeks after each treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Improvement Evaluations of Treated Facial Lines</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>Subject improvement evaluations will be made at each visit with exception to the first visit. Subjects will rate the percent improvement of the treated facial lines (0-25% Improvement, 25-49% Improvement, 50-74% Improvement, or 75-100% Improvement).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Rhytidosis Facialis</condition>
  <arm_group>
    <arm_group_label>Treated patients</arm_group_label>
    <description>Patients treated with blended Belotero for etched-in fine lines of the cutaneous lip, and/or radial cheek area, and/or nasolabial folds, and/or melolabial folds, and/or forehead area will be evaluated with photographs, physician ratings, and patient improvement assessments.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Blended Belotero</intervention_name>
    <description>Belotero blended with 0.1 cc of 1% lidocaine with epinephrine per 1.0 cc Belotero will be injected to etched in fine facial lines</description>
    <arm_group_label>Treated patients</arm_group_label>
    <other_name>Treated patients</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This is a single-center observational study of adult females and males ages 25 to 75 years
        who are scheduled to have treatment with Belotero blended with lidocaine with epinephrine,
        as is common in clinical practice for etched-in fine lines of the cutaneous lip, and/or
        radial cheek area, and/or nasolabial folds, and/or melolabial folds, and/or forehead area.
        After reviewing the risks and benefits of the procedure, the patient will sign a clinical
        consent form prior to treatment. If the patient is amenable to participate in the study and
        agrees to have pre and post treatment photographs and evaluations completed, they will
        proceed to sign the research consent form and will be enrolled into the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult females and males, aged 25-75 years.

          -  Subjects must be seeking treatment for etched-in fine lines of the cutaneous lip area,
             and/or radial cheek area, and/or nasolabial fold area, and/or melolabial fold area,
             and/or forehead area.

          -  Subjects must have one or more etched-in fine line on the cutaneous lip area, and/or
             radial cheek area, and/or nasolabial fold area, and/or melolabial fold area, and/or
             forehead area.

          -  Subjects must have been deemed eligible by the treating physician and be scheduled for
             treatment of etched-in fine facial lines with Belotero blended with lidocaine with
             epinephrine.

          -  Subjects must be willing to defer any other cosmetic procedures in the treatment area
             while in the study. They can continue using topicals with retinoids, retinol, beta
             hydroxy acids, or alpha hydroxyl acids if they were previously using these topicals
             for at least 3 months prior to starting the study, but they should not initiate
             cosmetic treatments with new topicals during the study period. They should not have
             cosmetic treatments such as chemical peels, microdermabrasion, microneedling
             procedures, laser procedures, botulinum toxin injections, or other injectable filler
             therapy in the treatment area during the study period.

          -  Subjects must be willing and able to provide written informed consent in English

          -  Subjects must be willing and able to follow the procedures outlined in this protocol.

        Exclusion Criteria:

          -  Subjects who are pregnant.

          -  Subjects with previous permanent injectable filler therapy to the treatment area.

          -  Subjects with previous non-permanent injectable filler therapy to the treatment area
             within the past year.

          -  Subjects with previous botulinum toxin injections in the treatment area within the
             past 6 months.

          -  Subjects with severe baseline facial lines in the treatment area with a score of 5
             based on the Validated Lemperle Facial Wrinkle Scales.

          -  Subjects with visible scars in the treatment area that may affect evaluation of
             response and/or quality of photography in the opinion of the investigator.

          -  Known allergy or sensitivity to any of the treatment injections or their components,
             including or known or suspected lidocaine hypersensitivity.

          -  Subjects with an infection in the treatment area.

          -  Subjects are not to undergo any additional cosmetic procedures in the treatment area
             during the study period.

          -  Subjects with a history of poor cooperation, non-compliance with medical treatment, or
             unrealiability.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Derek H Jones, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Skin Care and Laser Physicians of Beverly Hills</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Skin Care and Laser Physicians of Beverly Hills</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90069</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Carruthers A, Carruthers J, Hardas B, Kaur M, Goertelmeyer R, Jones D, Rzany B, Cohen J, Kerscher M, Flynn TC, Maas C, Sattler G, Gebauer A, Pooth R, McClure K, Simone-Korbel U, Buchner L. A validated grading scale for forehead lines. Dermatol Surg. 2008 Nov;34 Suppl 2:S155-60. doi: 10.1111/j.1524-4725.2008.34364.x.</citation>
    <PMID>19021673</PMID>
  </reference>
  <reference>
    <citation>Lemperle G, Holmes RE, Cohen SR, Lemperle SM. A classification of facial wrinkles. Plast Reconstr Surg. 2001 Nov;108(6):1735-50; discussion 1751-2.</citation>
    <PMID>11711957</PMID>
  </reference>
  <reference>
    <citation>Moradi A, Shirazi A, Moradi-Poehler J, Turner J, Howell DJ. A blinded, randomized, split-face pilot study of bruising and pain with hyaluronic acid for correction of perioral lines using no lidocaine, lidocaine alone, and lidocaine and epinephrine. Aesthet Surg J. 2015 May;35(4):443-55. doi: 10.1093/asj/sjv043.</citation>
    <PMID>25908703</PMID>
  </reference>
  <reference>
    <citation>Narins RS, Carruthers J, Flynn TC, Geister TL, GÃ¶rtelmeyer R, Hardas B, Himmrich S, Jones D, Kerscher M, de Maio M, Mohrmann C, Pooth R, Rzany B, Sattler G, Buchner L, Benter U, Breitscheidel L, Carruthers A. Validated assessment scales for the lower face. Dermatol Surg. 2012 Feb;38(2 Spec No.):333-42. doi: 10.1111/j.1524-4725.2011.02247.x.</citation>
    <PMID>22316189</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2015</study_first_submitted>
  <study_first_submitted_qc>December 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2015</study_first_posted>
  <last_update_submitted>December 7, 2015</last_update_submitted>
  <last_update_submitted_qc>December 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Skin Care and Laser Physicians of Beverly Hills</investigator_affiliation>
    <investigator_full_name>Derek H. Jones, M.D.</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>facial wrinkles</keyword>
  <keyword>photoaging</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

